INE232I01014
INE232I01014
SUN PHARMA ADV.RES.CO.LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 60.23B EUR | 76.22B EUR | 37.28B EUR | 43.6B EUR |
Enterprise Value | 65.81B EUR | 76.22B EUR | 42.85B EUR | 43.6B EUR |
Valuation Multiples | ||||
Trailing P/E | 3.8x | 4.81x | 2.4x | -- |
Forward P/E | 3.35x | -- | -- | -- |
Price to Sales | 3.15x | 3.99x | 1.98x | 168.01x |
Price to Book | 4.5x | -- | 2.78x | -- |
EV/Revenue | 3.45x | 3.99x | 2.28x | 168.01x |
EV/EBITDA | 4.05x | 4.64x | 2.66x | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |